SG11202012227PA - Method for producing dental pulp-derived cells - Google Patents
Method for producing dental pulp-derived cellsInfo
- Publication number
- SG11202012227PA SG11202012227PA SG11202012227PA SG11202012227PA SG11202012227PA SG 11202012227P A SG11202012227P A SG 11202012227PA SG 11202012227P A SG11202012227P A SG 11202012227PA SG 11202012227P A SG11202012227P A SG 11202012227PA SG 11202012227P A SG11202012227P A SG 11202012227PA
- Authority
- SG
- Singapore
- Prior art keywords
- derived cells
- dental pulp
- producing dental
- producing
- pulp
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N1/00—Preservation of bodies of humans or animals, or parts thereof
- A01N1/02—Preservation of living parts
- A01N1/0205—Chemical aspects
- A01N1/021—Preservation or perfusion media, liquids, solids or gases used in the preservation of cells, tissue, organs or bodily fluids
- A01N1/0221—Freeze-process protecting agents, i.e. substances protecting cells from effects of the physical process, e.g. cryoprotectants, osmolarity regulators like oncotic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/32—Bones; Osteocytes; Osteoblasts; Tendons; Tenocytes; Teeth; Odontoblasts; Cartilage; Chondrocytes; Synovial membrane
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/48—Reproductive organs
- A61K35/54—Ovaries; Ova; Ovules; Embryos; Foetal cells; Germ cells
- A61K35/545—Embryonic stem cells; Pluripotent stem cells; Induced pluripotent stem cells; Uncharacterised stem cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/20—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/42—Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/04—Drugs for skeletal disorders for non-specific disorders of the connective tissue
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/06—Lysis of microorganisms
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N11/00—Carrier-bound or immobilised enzymes; Carrier-bound or immobilised microbial cells; Preparation thereof
- C12N11/02—Enzymes or microbial cells immobilised on or in an organic carrier
- C12N11/08—Enzymes or microbial cells immobilised on or in an organic carrier the carrier being a synthetic polymer
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
- C12N5/0655—Chondrocytes; Cartilage
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
- C12N5/0662—Stem cells
- C12N5/0664—Dental pulp stem cells, Dental follicle stem cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0696—Artificially induced pluripotent stem cells, e.g. iPS
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/531—Production of immunochemical test materials
- G01N33/532—Production of labelled immunochemicals
- G01N33/533—Production of labelled immunochemicals with fluorescent label
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/05—Inorganic components
- C12N2500/10—Metals; Metal chelators
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/05—Inorganic components
- C12N2500/10—Metals; Metal chelators
- C12N2500/12—Light metals, i.e. alkali, alkaline earth, Be, Al, Mg
- C12N2500/14—Calcium; Ca chelators; Calcitonin
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/05—Inorganic components
- C12N2500/10—Metals; Metal chelators
- C12N2500/12—Light metals, i.e. alkali, alkaline earth, Be, Al, Mg
- C12N2500/16—Magnesium; Mg chelators
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/60—Buffer, e.g. pH regulation, osmotic pressure
- C12N2500/62—DMSO
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/70—Undefined extracts
- C12N2500/80—Undefined extracts from animals
- C12N2500/84—Undefined extracts from animals from mammals
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2506/00—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells
- C12N2506/13—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells from connective tissue cells, from mesenchymal cells
- C12N2506/1346—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells from connective tissue cells, from mesenchymal cells from mesenchymal stem cells
- C12N2506/1361—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells from connective tissue cells, from mesenchymal cells from mesenchymal stem cells from dental pulp or dental follicle stem cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2509/00—Methods for the dissociation of cells, e.g. specific use of enzymes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2523/00—Culture process characterised by temperature
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2533/00—Supports or coatings for cell culture, characterised by material
- C12N2533/50—Proteins
- C12N2533/54—Collagen; Gelatin
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Biomedical Technology (AREA)
- Immunology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Biotechnology (AREA)
- Zoology (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Developmental Biology & Embryology (AREA)
- Cell Biology (AREA)
- Wood Science & Technology (AREA)
- Rheumatology (AREA)
- Genetics & Genomics (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Epidemiology (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- Virology (AREA)
- General Engineering & Computer Science (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Reproductive Health (AREA)
- Physical Education & Sports Medicine (AREA)
- Hematology (AREA)
- Molecular Biology (AREA)
- Urology & Nephrology (AREA)
- Transplantation (AREA)
- Gynecology & Obstetrics (AREA)
- Pain & Pain Management (AREA)
- General Physics & Mathematics (AREA)
- Tropical Medicine & Parasitology (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2018143793 | 2018-07-31 | ||
PCT/JP2019/029913 WO2020027163A1 (ja) | 2018-07-31 | 2019-07-30 | 歯髄由来細胞の製造方法 |
Publications (1)
Publication Number | Publication Date |
---|---|
SG11202012227PA true SG11202012227PA (en) | 2021-01-28 |
Family
ID=69232494
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SG11202012227PA SG11202012227PA (en) | 2018-07-31 | 2019-07-30 | Method for producing dental pulp-derived cells |
Country Status (17)
Country | Link |
---|---|
US (1) | US20210301258A1 (he) |
EP (1) | EP3831935A4 (he) |
JP (2) | JPWO2020027163A1 (he) |
KR (1) | KR20210041578A (he) |
CN (1) | CN112469815A (he) |
AU (1) | AU2019316431A1 (he) |
BR (1) | BR112020026392A2 (he) |
CA (1) | CA3103769A1 (he) |
CL (1) | CL2021000208A1 (he) |
CO (1) | CO2021002009A2 (he) |
IL (1) | IL280387B2 (he) |
MX (1) | MX2021001029A (he) |
PH (1) | PH12021550212A1 (he) |
RU (1) | RU2022105712A (he) |
SG (1) | SG11202012227PA (he) |
TW (1) | TW202020144A (he) |
WO (1) | WO2020027163A1 (he) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU2021245671A1 (en) * | 2020-03-31 | 2022-10-20 | Cell Exosome Therapeutics Inc. | Cell preservation method |
KR20220122430A (ko) | 2021-02-25 | 2022-09-02 | 단국대학교 천안캠퍼스 산학협력단 | 조직재생을 위한 치수 줄기세포 추출 및 그의 배양 방법 |
JPWO2023120420A1 (he) * | 2021-12-20 | 2023-06-29 | ||
WO2023209175A1 (en) * | 2022-04-28 | 2023-11-02 | Bio-Recell Ltd. | Method for separating target cells |
WO2024075145A1 (ja) * | 2022-10-03 | 2024-04-11 | キッズウェル・バイオ株式会社 | 新規な歯髄幹細胞集団 |
WO2024075675A1 (ja) * | 2022-10-03 | 2024-04-11 | キッズウェル・バイオ株式会社 | 新規な歯髄幹細胞集団 |
WO2024075676A1 (ja) * | 2022-10-03 | 2024-04-11 | キッズウェル・バイオ株式会社 | 脳性まひの予防又は治療剤 |
WO2024172009A1 (ja) * | 2023-02-14 | 2024-08-22 | 国立大学法人山口大学 | 間葉系細胞を含む細胞集団、細胞集団を含む医薬組成物、細胞集団から得られたエクソソーム及び細胞集団を作製する方法 |
Family Cites Families (25)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5486359A (en) | 1990-11-16 | 1996-01-23 | Osiris Therapeutics, Inc. | Human mesenchymal stem cells |
US5827740A (en) | 1996-07-30 | 1998-10-27 | Osiris Therapeutics, Inc. | Adipogenic differentiation of human mesenchymal stem cells |
EP1007631B2 (en) | 1997-07-14 | 2009-02-18 | Osiris Therapeutics, Inc. | Cardiac muscle regeneration using mesenchymal stem cells |
US6835377B2 (en) | 1998-05-13 | 2004-12-28 | Osiris Therapeutics, Inc. | Osteoarthritis cartilage regeneration |
ES2423898T3 (es) | 2000-07-21 | 2013-09-25 | The Government Of The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Citoblastos de pulpa dental de seres humanos adultos in vitro e in vivo |
ATE397654T1 (de) | 2002-02-06 | 2008-06-15 | Stiftung Caesar | Aus zähnen gewonnene pluripotente embryonalähnliche stammzellen und verwendungen davon |
JP2004129549A (ja) | 2002-10-09 | 2004-04-30 | Yasuo Kitagawa | 脂肪由来細胞群からの間葉系幹細胞の選択的増殖方法 |
JP3953419B2 (ja) | 2002-12-26 | 2007-08-08 | 実 上田 | 未分化多能性細胞並びに、それを用いた関連組織又は歯作製方法 |
JP2004210713A (ja) | 2002-12-27 | 2004-07-29 | Asahi Kasei Corp | 医療用胎盤由来細胞製剤 |
ITNA20040043A1 (it) | 2004-07-28 | 2004-10-28 | Francesco Carinci | Tecnica di ingegneria tissutale ottenibile mediante isolamento di una nuova sottopopolazione di cellule staminali mbp-shed ed mbp-dpsc, isolate da polpa di denti decidui e permanenti in grado di produrre in vitro tessuto osseo umano. |
JP4734669B2 (ja) | 2005-02-04 | 2011-07-27 | 独立行政法人産業技術総合研究所 | ヒト歯乳頭からの幹細胞及びその利用方法 |
ITNA20060017A1 (it) | 2006-02-20 | 2007-08-21 | Aquino Riccardo D | Tecnica di prelievo e selezione di un una popolazione di cellule staminali di tipo embrionale da tessuti follicolari peridentari di uomo adulto. |
JP2008295420A (ja) | 2007-06-04 | 2008-12-11 | Niigata Univ | ヒト歯根膜細胞株、この細胞株から分化した造骨細胞およびこの造骨細胞から作製した人工骨 |
WO2009057537A1 (ja) * | 2007-11-02 | 2009-05-07 | Jcr Pharmaceuticals Co., Ltd. | ヒト間葉系幹細胞含有医薬組成物 |
WO2009072527A1 (ja) | 2007-12-05 | 2009-06-11 | National University Corporation Nagoya University | 歯髄幹細胞を用いた自家又は同種移植用組成物及びその用途 |
US20120028352A1 (en) * | 2008-03-17 | 2012-02-02 | Agency For Science, Technology And Research | Microcarriers for Stem Cell Culture |
ITRM20080342A1 (it) * | 2008-06-26 | 2009-12-27 | Univ Degli Studi Udine | Cellule di polpa dentale midollo-simili, metodi per isolamento ed uso. |
JP2010252778A (ja) | 2009-04-02 | 2010-11-11 | Shizui Bank Kk | 歯髄由来間葉系幹細胞の分離方法及び分離した幹細胞並びにそれらを用いた肝細胞系譜への分化 |
JP2010268715A (ja) | 2009-05-20 | 2010-12-02 | Nagoya Univ | 乳歯歯髄幹細胞に特徴的な遺伝子発現群の利用 |
JP5608927B2 (ja) | 2010-04-13 | 2014-10-22 | 国立大学法人名古屋大学 | 歯髄幹細胞を用いた神経疾患治療用組成物 |
JP6193214B2 (ja) * | 2012-03-29 | 2017-09-06 | Jcrファーマ株式会社 | 歯髄由来の多能性幹細胞の製造方法 |
CN103849595A (zh) * | 2012-12-05 | 2014-06-11 | 上海坤爱生物科技有限公司 | 牙髓干细胞的规模化生产工艺 |
WO2014185470A1 (ja) * | 2013-05-14 | 2014-11-20 | 株式会社再生医療推進機構 | 神経損傷の治療用移植材の製造方法 |
CN108369050B (zh) | 2015-12-10 | 2021-01-12 | Jcr制药股份有限公司 | 移动式低温工作台 |
IL261623B2 (he) * | 2016-03-09 | 2024-03-01 | Avita Int Ltd | תאי גזע המבטאים סמנים מזנכימליים ונוירונליים, הרכבים המכילים אותם ושיטות להכנתם |
-
2019
- 2019-07-30 JP JP2020534684A patent/JPWO2020027163A1/ja active Pending
- 2019-07-30 US US17/262,302 patent/US20210301258A1/en active Pending
- 2019-07-30 KR KR1020217005345A patent/KR20210041578A/ko unknown
- 2019-07-30 EP EP19844983.7A patent/EP3831935A4/en active Pending
- 2019-07-30 MX MX2021001029A patent/MX2021001029A/es unknown
- 2019-07-30 SG SG11202012227PA patent/SG11202012227PA/en unknown
- 2019-07-30 WO PCT/JP2019/029913 patent/WO2020027163A1/ja active Application Filing
- 2019-07-30 CA CA3103769A patent/CA3103769A1/en active Pending
- 2019-07-30 BR BR112020026392-3A patent/BR112020026392A2/pt unknown
- 2019-07-30 TW TW108127022A patent/TW202020144A/zh unknown
- 2019-07-30 RU RU2022105712A patent/RU2022105712A/ru unknown
- 2019-07-30 AU AU2019316431A patent/AU2019316431A1/en active Pending
- 2019-07-30 CN CN201980048888.7A patent/CN112469815A/zh active Pending
- 2019-07-30 IL IL280387A patent/IL280387B2/he unknown
-
2021
- 2021-01-26 CL CL2021000208A patent/CL2021000208A1/es unknown
- 2021-01-28 PH PH12021550212A patent/PH12021550212A1/en unknown
- 2021-02-19 CO CONC2021/0002009A patent/CO2021002009A2/es unknown
-
2024
- 2024-06-07 JP JP2024093271A patent/JP2024103800A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
EP3831935A1 (en) | 2021-06-09 |
IL280387A (he) | 2021-03-25 |
KR20210041578A (ko) | 2021-04-15 |
PH12021550212A1 (en) | 2021-10-18 |
TW202020144A (zh) | 2020-06-01 |
CL2021000208A1 (es) | 2021-08-20 |
MX2021001029A (es) | 2021-04-19 |
JPWO2020027163A1 (ja) | 2021-09-24 |
BR112020026392A2 (pt) | 2021-03-23 |
JP2024103800A (ja) | 2024-08-01 |
WO2020027163A1 (ja) | 2020-02-06 |
CO2021002009A2 (es) | 2021-03-08 |
AU2019316431A1 (en) | 2021-01-21 |
CN112469815A (zh) | 2021-03-09 |
CA3103769A1 (en) | 2020-02-06 |
IL280387B2 (he) | 2024-07-01 |
US20210301258A1 (en) | 2021-09-30 |
EP3831935A4 (en) | 2022-05-04 |
IL280387B1 (he) | 2024-03-01 |
RU2022105712A (ru) | 2022-04-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL280387A (he) | שיטה לייצור תאים הנגזרים מעיסת שיניים | |
EP3691559A4 (en) | AUTOMATED PROCESS FOR THE GENERATION OF DIGITAL INTERMEDIATE ORTHODONTIC SETTINGS | |
IL276597A (he) | שיטה לייצור תא אנטיגני נמוך | |
IL280041A (he) | שיטה לייצור תאי t גמא דלטא | |
EP3747996A4 (en) | METHOD OF MANUFACTURING CELLS | |
EP3678149A4 (en) | METHOD FOR PRODUCING A LGPS-BASED SOLID ELECTROLYTE | |
EP3598462A4 (en) | SOLID ELECTROLYTE MANUFACTURING PROCESS | |
EP3298131A4 (en) | Method for generating human dendritic cells for immunotherapy | |
GB201707143D0 (en) | Method for producing cells | |
EP3842522A4 (en) | PROCESS FOR THE PRODUCTION OF T-REGULATORY LYMPHOCYTES | |
PL3980471T3 (pl) | Sposób wytwarzania polimerów strukturalnych w postaci proszku poprzez żel | |
IL277467A (he) | שיטה לייצור תאי הרג טבעיים | |
EP3747624A4 (en) | METHOD OF MANUFACTURING THE STRUCTURE | |
IL280556A (he) | שיטה ייצור תא | |
EP3734620A4 (en) | TRANSPARENT ELECTRODE PRODUCTION PROCESS | |
PT3969640T (pt) | Célula de eletrólise e método de produção da célula de eletrólise | |
EP3828252C0 (en) | BIOFUEL PRODUCTION PROCESS | |
EP3831804A4 (en) | PROCESS FOR THE PRODUCTION OF 1-ACYLOXY-2-METHYL-2-PROPENE | |
EP3751643A4 (en) | METHOD OF MANUFACTURING A POSITIVELECTRODE | |
IL287063A (he) | שיטה לייצור מבנה דומה-ביורקמה | |
PL3733651T3 (pl) | Sposób wytwarzania kalkobutrolu | |
EP3569693A4 (en) | METHOD OF PREPARING A CELL CULTURE | |
EP3882347A4 (en) | METHODS FOR GENERATING GENOMEEDIT CELLS | |
EP3949897C0 (en) | METHOD FOR PRODUCING A DENTAL PROSTHESIS | |
EP3808839A4 (en) | METHOD FOR PRODUCING A TRANSFORMED CELL |